The shRNA-mediated depletion of HDAC3 also reduced the levels of p-ATR and p-CHK1 in HeLa cells, indicating that HDAC3 depletion inhibits the ATR-CHK1 pathway in cancer cells (Figure 4A). Here, HDAC3 is linked to cancer.